# Alcon and Lensar Call Off Merger

Page: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger
Text version: https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger.md
Podcast: [Eyewire News: The Podcast](https://stenobird.com/podcast/eyewire-news-the-podcast-7055536)
Published: 2026-03-18T19:31:00+00:00
Episode link: https://traffic.megaphone.fm/BMCL9514359622.mp3?updated=1773860036
Audio file: https://traffic.megaphone.fm/BMCL9514359622.mp3?updated=1773860036
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/alcon-and-lensar-call-off-merger
Duration seconds: 382

## Resource

Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/eyewire-news-the-podcast-7055536/episodes/alcon-and-lensar-call-off-merger/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/eyewire-news-the-podcast-7055536/alcon-and-lensar-call-off-merger.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.